Jane McLennan

2.4k total citations
16 papers, 1.7k citations indexed

About

Jane McLennan is a scholar working on Genetics, Cancer Research and Molecular Biology. According to data from OpenAlex, Jane McLennan has authored 16 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Genetics, 9 papers in Cancer Research and 7 papers in Molecular Biology. Recurrent topics in Jane McLennan's work include BRCA gene mutations in cancer (15 papers), Cancer Genomics and Diagnostics (8 papers) and DNA Repair Mechanisms (5 papers). Jane McLennan is often cited by papers focused on BRCA gene mutations in cancer (15 papers), Cancer Genomics and Diagnostics (8 papers) and DNA Repair Mechanisms (5 papers). Jane McLennan collaborates with scholars based in United States, Canada and Austria. Jane McLennan's co-authors include John L. Ziegler, Ping Sun, Nadine Tung, Henry T. Lynch, William D. Foulkes, Kelly Metcalfe, Steven A. Narod, Parviz Ghadirian, Ivo A. Olivotto and Olufunmilayo I. Olopade and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Clinical Cancer Research.

In The Last Decade

Jane McLennan

16 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jane McLennan United States	13	1.2k	678	495	454	448	16	1.7k
Linda Bradley United States	7	1.2k 1.0×	378 0.6×	480 1.0×	820 1.8×	517 1.2×	11	1.6k
Isabel Fan Canada	15	1.4k 1.1×	462 0.7×	569 1.1×	1.1k 2.4×	648 1.4×	16	2.0k
Joanne L. Blum United States	15	745 0.6×	521 0.8×	518 1.0×	224 0.5×	1.0k 2.2×	21	1.8k
Kathryn Alsop Australia	14	571 0.5×	385 0.6×	660 1.3×	701 1.5×	816 1.8×	24	1.5k
Jenny Permuth‐Wey United States	8	501 0.4×	507 0.7×	562 1.1×	428 0.9×	373 0.8×	10	1.2k
Angela George United Kingdom	17	596 0.5×	307 0.5×	412 0.8×	331 0.7×	564 1.3×	60	1.2k
Orland Dı́ez Spain	27	1.4k 1.2×	671 1.0×	1.2k 2.4×	127 0.3×	454 1.0×	94	2.2k
Amie M. Deffenbaugh United States	15	1.7k 1.4×	534 0.8×	1.0k 2.1×	209 0.5×	390 0.9×	19	2.1k
Catherine Emmanuel Australia	7	451 0.4×	234 0.3×	424 0.9×	568 1.3×	512 1.1×	9	1.0k
H. T. Lynch United States	9	545 0.5×	572 0.8×	281 0.6×	142 0.3×	885 2.0×	11	1.5k

Countries citing papers authored by Jane McLennan

Since Specialization

Citations

This map shows the geographic impact of Jane McLennan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jane McLennan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jane McLennan more than expected).

Fields of papers citing papers by Jane McLennan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jane McLennan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jane McLennan. The network helps show where Jane McLennan may publish in the future.

Co-authorship network of co-authors of Jane McLennan

This figure shows the co-authorship network connecting the top 25 collaborators of Jane McLennan. A scholar is included among the top collaborators of Jane McLennan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jane McLennan. Jane McLennan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Greenup, Rachel A., Adam H. Buchanan, Wendy Lorizio, et al.. (2013). Prevalence of BRCA Mutations Among Women with Triple-Negative Breast Cancer (TNBC) in a Genetic Counseling Cohort. Annals of Surgical Oncology. 20(10). 3254–3258. 170 indexed citations

Powell, C. Bethan, Lee-may Chen, Jane McLennan, et al.. (2011). Risk-Reducing Salpingo-Oophorectomy (RRSO) in BRCA Mutation Carriers. International Journal of Gynecological Cancer. 21(5). 846–851. 111 indexed citations

Chapman, Jocelyn, et al.. (2011). Surveillance of survivors: Follow-up after risk-reducing salpingo-oophorectomy in BRCA 1/2 mutation carriers. Gynecologic Oncology. 122(2). 339–343. 38 indexed citations

Sweet, Kevin, et al.. (2008). Clinically Applicable Models to CharacterizeBRCA1andBRCA2Variants of Uncertain Significance. Journal of Clinical Oncology. 26(33). 5393–5400. 62 indexed citations

Hwang, E. Shelley, et al.. (2007). Ductal Carcinoma In Situ in BRCA Mutation Carriers. Journal of Clinical Oncology. 25(6). 642–647. 51 indexed citations

Chen, Ying, Amanda E. Toland, Jane McLennan, et al.. (2006). Lack of Germ-Line Promoter Methylation in BRCA1 -Negative Families with Familial Breast Cancer. Genetic Testing. 10(4). 281–284. 19 indexed citations

Fridlyand, Jane, Antoine M. Snijders, Bauke Ylstra, et al.. (2006). Breast tumor copy number aberration phenotypes and genomic instability. BMC Cancer. 6(1). 96–96. 206 indexed citations

Fridlyand, Jane, Antoine M. Snijders, Bauke Ylstra, et al.. (2006). Breast tumor copy number aberration phenotypes and genomic instability - eScholarship. 1 indexed citations

Lee, Robin, Mary Beattie, Julie Mak, et al.. (2005). Recruitment, Genetic Counseling, and BRCA Testing for Underserved Women at a Public Hospital. Genetic Testing. 9(4). 306–312. 32 indexed citations

10.

Metcalfe, Kelly, Henry T. Lynch, P Ghadirian, et al.. (2005). The Risk of Ovarian Cancer After Breast Cancer in BRCA1 and BRCA2 Carriers. Obstetrical & Gynecological Survey. 60(4). 235–236. 9 indexed citations

11.

Metcalfe, Kelly, William D. Foulkes, Henry T. Lynch, et al.. (2005). Effect of Prior Bilateral Oophorectomy on the Presentation of Breast Cancer in BRCA1 and BRCA2 Mutation Carriers. Hereditary Cancer in Clinical Practice. 3(2). 53–7. 2 indexed citations

12.

Weitzel, Jeffrey N., Mark E. Robson, Barbara Pasini, et al.. (2005). A Comparison of Bilateral Breast Cancers in BRCA Carriers. Cancer Epidemiology Biomarkers & Prevention. 14(6). 1534–1538. 33 indexed citations

13.

Metcalfe, Kelly, Henry T. Lynch, Parviz Ghadirian, et al.. (2004). Contralateral Breast Cancer in BRCA1 and BRCA2 Mutation Carriers. Journal of Clinical Oncology. 22(12). 2328–2335. 435 indexed citations

14.

Foulkes, William D., Kelly Metcalfe, Ping Sun, et al.. (2004). Estrogen Receptor Status in BRCA1 - and BRCA2 -Related Breast Cancer. Clinical Cancer Research. 10(6). 2029–2034. 224 indexed citations

15.

Powell, C. Bethan, Lee-may Chen, Jane McLennan, et al.. (2004). Risk-Reducing Salpingo-Oophorectomy in BRCA Mutation Carriers: Role of Serial Sectioning in the Detection of Occult Malignancy. Journal of Clinical Oncology. 23(1). 127–132. 256 indexed citations

16.

Foulkes, William D., Kelly Metcalfe, Wedad Hanna, et al.. (2003). Disruption of the expected positive correlation between breast tumor size and lymph node status in BRCA1‐related breast carcinoma. Cancer. 98(8). 1569–1577. 84 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact